NASDAQ:LIFE

Atyr Pharma Stock Predictions

> Biotechnology

Buy LIFE

*Your capital is at risk

$16.89

-0.375 (-2.17%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

LIFE Prediction Chart

LIFE Predictions History

Latest community submissions for LIFE.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
JS Pro	Apr 3, 2019	$0.550 -92.46%	$0.521	V	94.47%	0
JS Pro	Jun 20, 2018	$1.08 -93.97%	$1.28	X	84.40%	0
JS Pro	Sep 29, 2017	$4.58 -93.52%	$5.05	V	90.70%	0
mitch.bagdigian.10816 Amateur	Sep 29, 2017	$4.80 -93.21%	$5.05	X	95.00%	0
JuanC Villegas Pro	Sep 29, 2017	$4.52 -93.61%	$5.05	V	89.50%	0
JS Pro	Jul 5, 2016	$2.82 -92.83%	$2.81	V	99.60%	4

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for LIFE with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT ATYR PHARMA INC

aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for treatment of other interstitial lung diseases (ILDs), such as chronic hypersensitivity pneumonitis and ...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by